ENVB · Enveric Biosciences, Inc.
$1.33
+0.00 (+0.00%)
At close · Jul 29
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed May 15, 2026
Market Cap
$4.90M
Shares
3.68M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-18 | 212 | $1.30 | $276 |
| 2026-06-17 | 1,041 | $1.37 | $1,426 |
| 2026-06-16 | 1,872 | $1.48 | $2,771 |
| 2026-06-15 | 5,727 | $1.53 | $8,762 |
| 2026-06-12 | 45 | $1.66 | $75 |
| 2026-06-11 | 2,758 | $1.62 | $4,468 |
| 2026-06-09 | 8,506 | $1.75 | $14,886 |
| 2026-05-28 | 2,922 | $2.14 | $6,253 |
| 2026-05-21 | 5,431 | $2.20 | $11,948 |
| 2026-05-20 | 14,960 | $2.11 | $31,566 |
| 2026-05-11 | 140,075 | $2.85 | $399,214 |
| 2026-05-08 | 140,549 | $3.17 | $445,540 |
| 2026-05-07 | 133,697 | $3.18 | $425,156 |
| 2026-05-06 | 134,514 | $3.48 | $468,109 |
| 2026-05-05 | 129,932 | $3.41 | $443,068 |
| 2026-05-04 | 103,772 | $3.99 | $414,050 |
| 2026-05-01 | 346,235 | $3.95 | $1,367,628 |
| 2026-04-30 | 15,296 | $5.16 | $78,927 |
| 2026-04-29 | 99,193 | $5.32 | $527,707 |
Showing 1–19 of 19 settlements